Inflammasomes: Sensors of metabolic stresses for vascular inflammation

Frontiers in Bioscience

Volumn 18, Issue 2, 2013, Pages 638-649

  Yin, Ying ^a   Pastrana, Jahaira Lopez ^a   Li, Xinyuan ^a   Huang, Xiao ^a   Mallilankaraman, Karthik ^a   Choi, Eric T ^a   Madesh, Muniswamy ^a   Wang, Hong ^a   Yang, Xiao Feng ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Caspase 1; Inflammasomes; Interleukin 1 beta; Review; ROS; Vascular Inflammation

Indexed keywords

CARRIER PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NLRP3 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; INFLAMMATION; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVIEW;

ATHEROSCLEROSIS; CARRIER PROTEINS; CASPASE 1; ENZYME ACTIVATION; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-1BETA; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL;

MLCS; MLOWN;

EID: 84878798988     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4127     Document Type: Review

References (83)

1. E. S. Ford, W. H. GilesandA. H. Mokdad: Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care, 27, 2444-9 (2004)
2. S. L. Masters, E. LatzandL. A. O'Neill: The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med, 3, 81ps17 (2011)
3. A. Halle, V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. MooreandD. T. Golenbock: The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol, 9, 857-65 (2008)
4. R. Zhou, A. Tardivel, B. Thorens, I. ChoiandJ. Tschopp: Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol, 11, 136-40 (2010)
5. B. Vandanmagsar, Y. H. Youm, A. Ravussin, J. E. Galgani, K. Stadler, R. L. Mynatt, E. Ravussin, J. M. StephensandV. D. Dixit: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med, 17, 179-88 (2011)
6. P. Duewell, H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nunez, M. Schnurr, T. Espevik, E. Lien, K. A. Fitzgerald, K. L. Rock, K. J. Moore, S. D. Wright, V. HornungandE. Latz: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 464, 1357-61 (2010)
7. S. L. Masters, A. Dunne, S. L. Subramanian, R. L. Hull, G. M. Tannahill, F. A. Sharp, C. Becker, L. Franchi, E. Yoshihara, Z. Chen, N. Mullooly, L. A. Mielke, J. Harris, R. C. Coll, K. H. Mills, K. H. Mok, P. Newsholme, G. Nunez, J. Yodoi, S. E. Kahn, E. C. LavelleandL. A. O'Neill: Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol, 11, 897-904 (2010)
8. F. D. Kolodgie, J. Narula, A. P. Burke, N. Haider, A. Farb, Y. Hui-Liang, J. SmialekandR. Virmani: Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol, 157, 1259-68 (2000)
9. H. J. Ankersmit, T. Weber, J. Auer, G. Roth, M. Brunner, E. Kvas, B. Moser, S. Spreitzer, E. Lassnig, E. Maurer, P. Hartl, E. Wolner, G. Boltz-NitulescuandB. Eber: Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina. Heart, 90, 151-4 (2004) (Pubitemid 38147146)
10. Z. B. OzcakarandF. Yalcinkaya: Vascular comorbidities in familial Mediterranean fever. Rheumatol Int, 31, 1275-81 (2011)
11. M. P. Grimaldi, G. Candore, S. Vasto, M. Caruso, G. Caimi, E. Hoffmann, G. Colonna-Romano, D. Lio, Y. Shinar, C. FranceschiandC. Caruso: Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol, 79, 611-5 (2006) (Pubitemid 44831237)
12. A. Akdogan, M. Calguneri, B. Yavuz, E. B. Arslan, U. Kalyoncu, L. Sahiner, O. Karadag, I. Ertenli, S. Kiraz, K. Aytemir, D. Akata, L. TokgozogluandA. Oto: Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol, 48, 2351-3 (2006)
13. S. Ugurlu, E. Seyahi, F. Cetinkaya, F. Ozbakir, H. BalciandH. Ozdogan: Intima-media thickening in patients with familial Mediterranean fever. Rheumatology (Oxford), 48, 911-5 (2009)
14. T. Bergsbaken, S. L. FinkandB. T. Cookson: Pyroptosis: host cell death and inflammation. Nat Rev Microbiol, 7, 99- 109 (2009)
15. M. J. Kostura, M. J. Tocci, G. Limjuco, J. Chin, P. Cameron, A. G. Hillman, N. A. ChartrainandJ. A. Schmidt: Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A, 86, 5227-31 (1989) (Pubitemid 19185528)
16. J. Yuan, S. Shaham, S. Ledoux, H. M. EllisandH. R. Horvitz: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 75, 641-52 (1993) (Pubitemid 23346363)
17. S. J. RiedlandY. Shi: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol, 5, 897- 907 (2004) (Pubitemid 39486541)
18. F. MartinonandJ. Tschopp: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ, 14, 10-22 (2007) (Pubitemid 44911890)
19. F. MartinonandJ. Tschopp: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell, 117, 561-74 (2004) (Pubitemid 38692523)
20. Y. Xue, A. Daly, B. Yngvadottir, M. Liu, G. Coop, Y. Kim, P. Sabeti, Y. Chen, J. Stalker, E. Huckle, J. Burton, S. Leonard, J. RogersandC. Tyler-Smith: Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet, 78, 659-70 (2006)
21. J. Shen, Y. Yin, J. Mai, X. Xiong, M. Pansuria, J. Liu, E. Maley, N. U. Saqib, H. WangandX. F. Yang: Caspase-1 recognizes extended cleavage sites in its natural substrates. Atherosclerosis, 210, 422-9 (2010)
22. N. Kayagaki, S. Warming, M. Lamkanfi, L. Vande Walle, S. Louie, J. Dong, K. Newton, Y. Qu, J. Liu, S. Heldens, J. Zhang, W. P. Lee, M. Roose-GirmaandV. M. Dixit: Non-canonical inflammasome activation targets caspase-11. Nature, 479, 117-21 (2011)
23. P. D. MaceandS. J. Riedl: Molecular cell death platforms and assemblies. Curr Opin Cell Biol, 22, 828-36 (2010)
24. V. A. Rathinam, S. K. VanajaandK. A. Fitzgerald: Regulation of inflammasome signaling. Nat Immunol, 13, 333-2 (2012)
25. E. D. BoydenandW. F. Dietrich: Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet, 38, 240-4 (2006) (Pubitemid 43177241)
26. Y. Zhao, J. Yang, J. Shi, Y. N. Gong, Q. Lu, H. Xu, L. LiuandF. Shao: The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature, 477, 596-600 (2011)
27. V. HornungandE. Latz: Intracellular DNA recognition. Nat Rev Immunol, 10, 123-30 (2010)
28. N. Kerur, M. V. Veettil, N. Sharma-Walia, V. Bottero, S. Sadagopan, P. OtageriandB. Chandran: IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe, 9, 363-75 (2011)
29. T. Fernandes-Alnemri, J. W. Yu, P. Datta, J. WuandE. S. Alnemri: AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature, 458, 509-13 (2009)
30. V. Hornung, F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. FitzgeraldandE. Latz: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol, 9, 847-56 (2008)
31. F. G. Bauernfeind, G. Horvath, A. Stutz, E. S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B. G. Monks, K. A. Fitzgerald, V. HornungandE. Latz: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 183, 787-91 (2009)
32. G. Guarda, M. Zenger, A. S. Yazdi, K. Schroder, I. Ferrero, P. Menu, A. Tardivel, C. MattmannandJ. Tschopp: Differential expression of NLRP3 among hematopoietic cells. J Immunol, 186, 2529-34 (2011)
33. V. HornungandE. Latz: Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol, 40, 620-3 (2010)
34. H. M. HoffmanandS. D. Brydges: Genetic and molecular basis of inflammasome-mediated disease. J Biol Chem, 286, 10889-96 (2011)
35. T. Strowig, J. Henao-Mejia, E. ElinavandR. Flavell: Inflammasomes in health and disease. Nature, 481, 278-86 (2012)
36. V. Petrilli, S. Papin, C. Dostert, A. Mayor, F. MartinonandJ. Tschopp: Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ, 14, 1583-9 (2007)
37. T. D. Kanneganti, M. Lamkanfi, Y. G. Kim, G. Chen, J. H. Park, L. Franchi, P. VandenabeeleandG. Nunez: Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Tolllike receptor signaling. Immunity, 26, 433-43 (2007) (Pubitemid 46603000)
38. S. C. Eisenbarth, O. R. Colegio, W. O'Connor, F. S. SutterwalaandR. A. Flavell: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature, 453, 1122-6 (2008)
39. C. Dostert, V. Petrilli, R. Van Bruggen, C. Steele, B. T. MossmanandJ. Tschopp: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science, 320, 674-7 (2008) (Pubitemid 351928351)
40. A. J. Kowaltowski, N. C. de Souza-Pinto, R. F. CastilhoandA. E. Vercesi: Mitochondria and reactive oxygen species. Free Radic Biol Med, 47, 333-43 (2009)
41. N. Saha, F. Moldovan, G. Tardif, J. P. Pelletier, J. M. CloutierandJ. Martel-Pelletier: Interleukin-1betaconverting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18. Arthritis Rheum, 42, 1577-87 (1999) (Pubitemid 30263623)
42. L. A. O'Neill: The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev, 226, 10-8 (2008)
43. H. Kirii, T. Niwa, Y. Yamada, H. Wada, K. Saito, Y. Iwakura, M. Asano, H. MoriwakiandM. Seishima: Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 23, 656-60 (2003) (Pubitemid 36438080)
44. X. Wang, G. Z. Feuerstein, J. L. Gu, P. G. LyskoandT. L. Yue: Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis, 115, 89-98 (1995)
45. M. A. Perrella, C. Patterson, L. Tan, S. F. Yet, C. M. Hsieh, M. YoshizumiandM. E. Lee: Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. J Biol Chem, 271, 13776-80 (1996)
46. A. Ito, A. Mukaiyama, Y. Itoh, H. Nagase, I. B. Thogersen, J. J. Enghild, Y. SasaguriandY. Mori: Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem, 271, 14657-60 (1996)
47. S. C. Whitman, P. RavisankarandA. Daugherty: Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res, 90, E34-8 (2002)
48. F. Favilli, C. Anzilotti, L. Martinelli, P. Quattroni, S. De Martino, F. Pratesi, D. Neumann, S. Beermann, D. Novick, C. A. Dinarello, D. BoraschiandP. Migliorini: IL-18 activity in systemic lupus erythematosus. Ann N Y Acad Sci, 1173, 301-9 (2009)
49. P. ReddyandJ. L. Ferrara: Role of interleukin-18 in acute graft-vs-host disease. J Lab Clin Med, 141, 365-71 (2003) (Pubitemid 36737148)
50. K. Kimura, K. Kakimi, S. Wieland, L. G. GuidottiandF. V. Chisari: Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol, 76, 10702-7 (2002)
51. M. G. Netea, L. A. Joosten, E. Lewis, D. R. Jensen, P. J. Voshol, B. J. Kullberg, C. J. Tack, H. van Krieken, S. H. Kim, A. F. Stalenhoef, F. A. van de Loo, I. Verschueren, L. Pulawa, S. Akira, R. H. Eckel, C. A. Dinarello, W. van den BergandJ. W. van der Meer: Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med, 12, 650-6 (2006) (Pubitemid 43865233)
52. A. Sarkar, M. W. Hall, M. Exline, J. Hart, N. Knatz, N. T. GatsonandM. D. Wewers: Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med, 174, 1003-10 (2006) (Pubitemid 44684449)
53. Y. Chen, M. R. Smith, K. ThirumalaiandA. Zychlinsky: A bacterial invasin induces macrophage apoptosis by binding directly to ICE. Embo J, 15, 3853-60 (1996) (Pubitemid 26289795)
54. D. M. Monack, C. S. DetweilerandS. Falkow: Salmonella pathogenicity island 2-dependent macrophage death is mediated in part by the host cysteine protease caspase-1. Cell Microbiol, 3, 825-37 (2001) (Pubitemid 33133478)
55. S. L. Fink, T. BergsbakenandB. T. Cookson: Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A, 105, 4312-7 (2008)
56. S. L. FinkandB. T. Cookson: Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol, 8, 1812-25 (2006) (Pubitemid 44530672)
57. K. Kuida, J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. SuandR. A. Flavell: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science, 267, 2000-3 (1995)
58. M. Keller, A. Ruegg, S. WernerandH. D. Beer: Active caspase-1 is a regulator of unconventional protein secretion. Cell, 132, 818-31 (2008) (Pubitemid 351312798)
59. A. Rubartelli, F. Cozzolino, M. TalioandR. Sitia: A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. Embo J, 9, 1503-10 (1990)
60. J. Staal, T. BekaertandR. Beyaert: Regulation of NFkappaB signaling by caspases and MALT1 paracaspase. Cell Res, 21, 40-54 (2011)
61. M. Lamkanfi, M. Kalai, X. Saelens, W. DeclercqandP. Vandenabeele: Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem, 279, 24785-93 (2004)
62. M. Lamkanfi, G. Denecker, M. Kalai, K. D'Hondt, A. Meeus, W. Declercq, X. SaelensandP. Vandenabeele: INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem, 279, 51729-38 (2004)
63. U. LakshmananandA. G. Porter: Caspase-4 interacts with TNF receptor-associated factor 6 and mediates lipopolysaccharide-induced NF-kappaB-dependent production of IL-8 and CC chemokine ligand 4 (macrophageinflammatory protein-1). J Immunol, 179, 8480-90 (2007)
64. P. M. LeBlanc, G. Yeretssian, N. Rutherford, K. Doiron, A. Nadiri, L. Zhu, D. R. Green, S. GruenheidandM. Saleh: Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe, 3, 146-57 (2008) (Pubitemid 351325760)
65. M. G. Vander Heiden, L. C. CantleyandC. B. Thompson: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-33 (2009)
66. A. Garedew, S. O. HendersonandS. Moncada: Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ, 17, 1540-50 (2010)
67. J. C. Rodriguez-Prados, P. G. Traves, J. Cuenca, D. Rico, J. Aragones, P. Martin-Sanz, M. CascanteandL. Bosca: Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol, 185, 605-14 (2010)
68. S. E. Calvano, W. Xiao, D. R. Richards, R. M. Felciano, H. V. Baker, R. J. Cho, R. O. Chen, B. H. Brownstein, J. P. Cobb, S. K. Tschoeke, C. Miller-Graziano, L. L. Moldawer, M. N. Mindrinos, R. W. Davis, R. G. TompkinsandS. F. Lowry: A network-based analysis of systemic inflammation in humans. Nature, 437, 1032-7 (2005)
69. C. M. Krawczyk, T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. DeBerardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. JonesandE. J. Pearce: Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood, 115, 4742-9 (2010)
70. W. Shao, G. Yeretssian, K. Doiron, S. N. HussainandM. Saleh: The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem, 282, 36321-9 (2007)
71. F. Merhi-Soussi, B. R. Kwak, D. Magne, C. Chadjichristos, M. Berti, G. Pelli, R. W. James, F. MachandC. Gabay: Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein Eknockout mice. Cardiovasc Res, 66, 583-93 (2005) (Pubitemid 40725770)
72. J. Galea, J. Armstrong, P. Gadsdon, H. Holden, S. E. FrancisandC. M. Holt: Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol, 16, 1000-6 (1996)
73. Z. Mallat, A. Corbaz, A. Scoazec, S. Besnard, G. Leseche, Y. ChvatchkoandA. Tedgui: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation, 104, 1598-603 (2001) (Pubitemid 32947520)
74. R. Elhage, J. Jawien, M. Rudling, H. G. Ljunggren, K. Takeda, S. Akira, F. BayardandG. K. Hansson: Reduced atherosclerosis in interleukin-18 deficient apolipoprotein Eknockout mice. Cardiovasc Res, 59, 234-40 (2003) (Pubitemid 36776389)
75. K. Isoda, S. Sawada, N. Ishigami, T. Matsuki, K. Miyazaki, M. Kusuhara, Y. IwakuraandF. Ohsuzu: Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 24, 1068-73 (2004) (Pubitemid 38737833)
76. C. Erridge: The roles of pathogen-associated molecular patterns in atherosclerosis. Trends Cardiovasc Med, 18, 52- 6 (2008) (Pubitemid 351282493)
77. S. Blankenberg, T. Godefroy, O. Poirier, H. J. Rupprecht, S. Barbaux, C. Bickel, V. Nicaud, R. Schnabel, F. Kee, C. Morrison, A. Evans, K. J. Lackner, F. Cambien, T. MunzelandL. Tiret: Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. Circ Res, 99, 102-8 (2006) (Pubitemid 44297061)
78. P. Duewell, H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, F. G. Bauernfeind, G. S. Abela, L. Franchi, G. Nunez, M. Schnurr, T. Espevik, E. Lien, K. A. Fitzgerald, K. L. Rock, K. J. Moore, S. D. Wright, V. HornungandE. Latz: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 464, 1357-61 (2010)
79. P. Menu, M. Pellegrin, J. F. Aubert, K. Bouzourene, A. Tardivel, L. MazzolaiandJ. Tschopp: Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis, 2, e137 (2011)
80. C. F. Moyer, D. Sajuthi, H. TulliandJ. K. Williams: Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol, 138, 951-60 (1991)
81. Y. Yin, Y. Yan, X. Jiang, J. Mai, N. C. Chen, H. WangandX. F. Yang: Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol, 22, 311-22 (2009)
82. M. Lamkanfi, J. L. Mueller, A. C. Vitari, S. Misaghi, A. Fedorova, K. Deshayes, W. P. Lee, H. M. HoffmanandV. M. Dixit: Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol, 187, 61-70 (2009)
83. J. C. Randle, M. W. Harding, G. Ku, M. SchonhartingandR. Kurrle: ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs. Expert Opin Investig Drugs, 10, 1207-9 (2001)